跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
UNI-MONTELUKAST - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
UNI-MONTELUKAST
Authorized
STANDARD
UNI-MONTELUKAST
UNIMARK REMEDIES LIMITED
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
6ee88a130b46e334
Company
UNIMARK REMEDIES LIMITED
Type
Standard
Approval Details
Approval Id
6ee88a130b46e334
Drug Approval Canada Name
UNI-MONTELUKAST
Product Name
UNI-MONTELUKAST
Status
Cancelled (Unreturned Annual)
Status Date
2018-04-04
Din
02396793
Drug Class
Human
Dosage Form
Tablet (Chewable)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
48:10.24
Atc Original
R03DC03 MONTELUKAST
Atc Name
r 03 dc 03
Aig Number
0133823003
Company Name
UNIMARK REMEDIES LIMITED
Company Address
Fact: 337, Kerala Nalsarovar Road, Kerala, Bavla, Ahmedabad, Gujarat, India, 382220
Company Detail Path
/organization/unimark-remedies-limited
Company Information
Pharmaceutical Company Name
UNIMARK REMEDIES LIMITED
Country Name
India
Address
18
Active Ingredients
MONTELUKAST (MONTELUKAST SODIUM)
4 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
6ee88a130b46e334
Type
Standard
Back to Health Canada Approvals